CCL2 also exerts TAM-independent effects on tumor cells and the TME, such as recruiting other myeloid subsets and non-myeloid cells, which sustains an immunosuppressive environment, stimulates tumor cell growth and motility, and further promotes angiogenesis [11]. The gene discussed is CCL2; the disease is neoplasm.